China National Accord Medicines Corporation Ltd. (000028.SZ)
CNY 29.96
(-0.5%)
CNY 29.96
(-0.5%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.34 Billion CNY | 1.21% |
| 2022 | 2.3 Billion CNY | 18.11% |
| 2021 | 1.95 Billion CNY | -9.77% |
| 2020 | 2.16 Billion CNY | 17.89% |
| 2019 | 1.83 Billion CNY | 9.85% |
| 2018 | 1.67 Billion CNY | 14.15% |
| 2017 | 1.46 Billion CNY | -5.44% |
| 2016 | 1.54 Billion CNY | 70.77% |
| 2015 | 906.59 Million CNY | 16.01% |
| 2014 | 781.48 Million CNY | 21.16% |
| 2013 | 645 Million CNY | 12.87% |
| 2012 | 571.46 Million CNY | 47.64% |
| 2011 | 387.06 Million CNY | 19.87% |
| 2010 | 322.89 Million CNY | 28.16% |
| 2009 | 251.94 Million CNY | 36.7% |
| 2008 | 184.29 Million CNY | 8.84% |
| 2007 | 169.32 Million CNY | 66.95% |
| 2006 | 101.42 Million CNY | 143.28% |
| 2005 | 41.68 Million CNY | 94.56% |
| 2004 | 21.42 Million CNY | 350.32% |
| 2003 | 4.75 Million CNY | 162.58% |
| 2002 | -7.6 Million CNY | -130.83% |
| 2001 | 24.66 Million CNY | 245.65% |
| 2000 | -16.93 Million CNY | -150.63% |
| 1999 | 33.44 Million CNY | 226.17% |
| 1998 | 10.25 Million CNY | 136.6% |
| 1997 | -28.01 Million CNY | -174.07% |
| 1996 | 37.82 Million CNY | 46.77% |
| 1995 | 25.77 Million CNY | -24.75% |
| 1994 | 34.24 Million CNY | -10.7% |
| 1993 | 38.34 Million CNY | 43.77% |
| 1992 | 26.67 Million CNY | -57.25% |
| 1991 | 62.38 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 464.93 Million CNY | -31.38% |
| 2024 Q3 | 395.58 Million CNY | -2.29% |
| 2024 Q2 | 404.85 Million CNY | -12.92% |
| 2023 FY | 2.33 Billion CNY | 1.21% |
| 2023 Q1 | 576.35 Million CNY | -22.31% |
| 2023 Q2 | 718.76 Million CNY | 24.71% |
| 2023 Q3 | 527.8 Million CNY | -26.57% |
| 2023 Q4 | 677.54 Million CNY | 28.37% |
| 2022 Q1 | 375.07 Million CNY | 4.39% |
| 2022 FY | 2.3 Billion CNY | 18.11% |
| 2022 Q4 | 741.82 Million CNY | 39.48% |
| 2022 Q3 | 531.85 Million CNY | -19.09% |
| 2022 Q2 | 657.31 Million CNY | 75.25% |
| 2021 FY | 1.95 Billion CNY | -9.77% |
| 2021 Q1 | 471.34 Million CNY | -25.69% |
| 2021 Q2 | 665.82 Million CNY | 41.26% |
| 2021 Q3 | 455.93 Million CNY | -31.52% |
| 2021 Q4 | 359.3 Million CNY | -21.19% |
| 2020 Q3 | 515.46 Million CNY | -19.62% |
| 2020 Q2 | 641.32 Million CNY | 72.04% |
| 2020 Q1 | 372.77 Million CNY | -15.24% |
| 2020 Q4 | 634.26 Million CNY | 23.05% |
| 2020 FY | 2.16 Billion CNY | 17.89% |
| 2019 Q3 | 437.36 Million CNY | -18.03% |
| 2019 Q4 | 439.79 Million CNY | 0.56% |
| 2019 Q1 | 424.83 Million CNY | -0.01% |
| 2019 Q2 | 533.54 Million CNY | 25.59% |
| 2019 FY | 1.83 Billion CNY | 9.85% |
| 2018 Q2 | 467.96 Million CNY | 22.48% |
| 2018 FY | 1.67 Billion CNY | 14.15% |
| 2018 Q4 | 424.87 Million CNY | 7.28% |
| 2018 Q3 | 396.06 Million CNY | -15.36% |
| 2018 Q1 | 382.06 Million CNY | 3.3% |
| 2017 Q1 | 364.42 Million CNY | -45.44% |
| 2017 Q2 | 392.17 Million CNY | 7.61% |
| 2017 Q3 | 337.42 Million CNY | -13.96% |
| 2017 FY | 1.46 Billion CNY | -5.44% |
| 2017 Q4 | 369.87 Million CNY | 9.61% |
| 2016 Q2 | 397.96 Million CNY | 55.75% |
| 2016 Q4 | 667.95 Million CNY | 194.61% |
| 2016 FY | 1.54 Billion CNY | 70.77% |
| 2016 Q1 | 255.51 Million CNY | 35.43% |
| 2016 Q3 | 226.72 Million CNY | -43.03% |
| 2015 Q3 | 235.46 Million CNY | 2.01% |
| 2015 Q2 | 230.82 Million CNY | -8.27% |
| 2015 Q1 | 251.62 Million CNY | 45.79% |
| 2015 Q4 | 188.67 Million CNY | -19.87% |
| 2015 FY | 906.59 Million CNY | 16.01% |
| 2014 FY | 781.48 Million CNY | 21.16% |
| 2014 Q4 | 172.59 Million CNY | -11.43% |
| 2014 Q3 | 194.87 Million CNY | -5.4% |
| 2014 Q2 | 205.99 Million CNY | -2.28% |
| 2014 Q1 | 210.79 Million CNY | 44.22% |
| 2013 FY | 645 Million CNY | 12.87% |
| 2013 Q2 | 149.84 Million CNY | -16.23% |
| 2013 Q1 | 178.87 Million CNY | 70.32% |
| 2013 Q3 | 170.11 Million CNY | 13.53% |
| 2013 Q4 | 146.16 Million CNY | -14.08% |
| 2012 Q3 | 148.47 Million CNY | -9.64% |
| 2012 Q1 | 153.64 Million CNY | 88.11% |
| 2012 Q2 | 164.31 Million CNY | 6.94% |
| 2012 FY | 571.46 Million CNY | 47.64% |
| 2012 Q4 | 105.02 Million CNY | -29.26% |
| 2011 FY | 387.06 Million CNY | 19.87% |
| 2011 Q4 | 81.68 Million CNY | -20.28% |
| 2011 Q3 | 102.46 Million CNY | 13.55% |
| 2011 Q2 | 90.23 Million CNY | -19.92% |
| 2011 Q1 | 112.68 Million CNY | 38.32% |
| 2010 FY | 322.89 Million CNY | 28.16% |
| 2010 Q1 | 81.25 Million CNY | 35.73% |
| 2010 Q2 | 77.8 Million CNY | -4.25% |
| 2010 Q3 | 82.37 Million CNY | 5.87% |
| 2010 Q4 | 81.46 Million CNY | -1.1% |
| 2009 Q4 | 59.86 Million CNY | 5.63% |
| 2009 FY | 251.94 Million CNY | 36.7% |
| 2009 Q2 | 75.52 Million CNY | 26.16% |
| 2009 Q3 | 56.67 Million CNY | -24.96% |
| 2009 Q1 | 59.86 Million CNY | 47.35% |
| 2008 FY | 184.29 Million CNY | 8.84% |
| 2008 Q4 | 40.63 Million CNY | -19.9% |
| 2008 Q3 | 50.72 Million CNY | 10.91% |
| 2008 Q2 | 45.73 Million CNY | -3.11% |
| 2008 Q1 | 47.2 Million CNY | 92.24% |
| 2007 FY | 169.32 Million CNY | 66.95% |
| 2007 Q4 | 24.55 Million CNY | -61.44% |
| 2007 Q3 | 63.67 Million CNY | 45.33% |
| 2007 Q2 | 43.81 Million CNY | 17.52% |
| 2007 Q1 | 37.28 Million CNY | 274.12% |
| 2006 Q2 | 32.88 Million CNY | 25.27% |
| 2006 Q3 | 32.32 Million CNY | -1.7% |
| 2006 FY | 101.42 Million CNY | 143.28% |
| 2006 Q4 | 9.96 Million CNY | -69.17% |
| 2006 Q1 | 26.25 Million CNY | 269.74% |
| 2005 Q3 | 9.85 Million CNY | -7.69% |
| 2005 Q4 | 7.09 Million CNY | -27.97% |
| 2005 Q1 | 14.05 Million CNY | 491.75% |
| 2005 FY | 41.68 Million CNY | 94.56% |
| 2005 Q2 | 10.67 Million CNY | -24.05% |
| 2004 FY | 21.42 Million CNY | 350.32% |
| 2004 Q3 | 5.53 Million CNY | -43.62% |
| 2004 Q2 | 9.82 Million CNY | 166.13% |
| 2004 Q1 | 3.69 Million CNY | 259.43% |
| 2004 Q4 | 2.37 Million CNY | -57.11% |
| 2003 FY | 4.75 Million CNY | 162.58% |
| 2003 Q1 | 402.07 Thousand CNY | 103.33% |
| 2003 Q2 | 2.71 Million CNY | 575.2% |
| 2003 Q3 | 614.55 Thousand CNY | -77.36% |
| 2003 Q4 | 1.02 Million CNY | 67.1% |
| 2002 Q1 | -1.18 Million CNY | 94.74% |
| 2002 Q4 | -12.09 Million CNY | -190313.57% |
| 2002 Q3 | -6349.60 CNY | -100.11% |
| 2002 Q2 | 5.67 Million CNY | 579.03% |
| 2002 FY | -7.6 Million CNY | -130.83% |
| 2001 FY | 24.66 Million CNY | 245.65% |
| 2001 Q4 | -22.55 Million CNY | -202.97% |
| 2001 Q3 | -7.44 Million CNY | 0.0% |
| 2000 FY | -16.93 Million CNY | -150.63% |
| 1999 FY | 33.44 Million CNY | 226.17% |
| 1998 FY | 10.25 Million CNY | 136.6% |
| 1997 FY | -28.01 Million CNY | -174.07% |
| 1996 FY | 37.82 Million CNY | 46.77% |
| 1995 FY | 25.77 Million CNY | -24.75% |
| 1994 FY | 34.24 Million CNY | -10.7% |
| 1993 FY | 38.34 Million CNY | 43.77% |
| 1992 FY | 26.67 Million CNY | -57.25% |
| 1991 FY | 62.38 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Shenzhen Glory Medical Co.,Ltd. | -121.22 Million CNY | 2036.262% |
| Realcan Pharmaceutical Group Co., Ltd. | -126.63 Million CNY | 1953.513% |